45 employees
ISA Pharmaceuticals is a developer of synthetic therapeutic vaccines designed to provide treatment for cancer.
2004
$22M
from 1 investors over 1 rounds
ISA Pharmaceuticals raised $22M on October 14, 2019
Investors: European Investment Bank